A Food and Drug Administration advisory panel on Tuesday voted to endorse emergency use authorization for Merck’s experimental COVID-19 pill.
A Food and Drug Administration advisory panel on Tuesday voted to endorse emergency use authorization for Merck’s experimental COVID-19 pill.